NeuroOne Medical Technologies Corporation (NMTC)

Market Cap	38.86M +104.6%
Revenue (ttm)	12.72M +120.9%
Net Income	-6.64M
EPS	-0.83
Shares Out	8.45M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	118,296
Open	4.570
Previous Close	4.510
Day's Range	4.190 - 4.700
52-Week Range	3.274 - 6.960
Beta	0.58
Analysts	Strong Buy
Price Target	11.93 (+159.35%)
Earnings Date	May 12, 2026

About NMTC

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 18
• Stock Exchange: NASDAQ
• Ticker Symbol: NMTC
• Website: https://nmtc1.com

Financial Performance

In fiscal year 2025, NMTC's revenue was $12.10 million, an increase of 250.35% compared to the previous year's $3.45 million. Losses were -$3.61 million, -70.73% less than in 2024.

Analyst Summary

According to 3 analysts, the average rating for NMTC stock is "Strong Buy." The 12-month stock price target is $11.93, which is an increase of 159.35% from the latest price.

Price Target

$11.93

(159.35% upside)

Analyst Consensus: Strong Buy